Abstract
Objective: To determine whether patients with non-ST elevation acute coronary syndromes requiring coronary angiography and revascularisation have inferior access to these services if admitted to district general hospitals (DGHs) compared with similar patients admitted to a base hospital containing a tertiary cardiac centre.
Design: Prospective, consecutive monitoring of all patients with acute coronary syndromes accepted by the tertiary cardiac centre for angiography and revascularisation over a three month period (1 April to 30 June 2002).
Participants: All patients accepted for angiography from DGHs and from within the base hospital with a diagnosis of acute coronary syndromes.
Setting: Tertiary cardiac facility (Manchester Heart Centre at Manchester Royal Infirmary (MRI)).
Main outcome measure: Time waited from referral to angiography and revascularisation.
Results: A total of 184 patients with a diagnosis of non-ST elevation acute coronary syndromes underwent angiography with a view to revascularisation. Of these, 89 (48%) were admitted initially to MRI and 95 (52%) were admitted to a feeder DGH. DGH patients waited significantly longer from admission to angiography than MRI patients (median 13 days (25th-75th percentiles 7–19) v 5 days (3–8) respectively; p<0.0005). DGH patients therefore also waited longer from admission to revascularisation (15 days (6–20) v 6 days (3–9) respectively). Once transferred into the Manchester Heart Centre, DGH patients underwent angiography within a median of 1 day (1–2). More DGH patients than those from MRI underwent both coronary artery bypass grafting (21 (22%) v 8 (9%) respectively; p=0.015) and percutaneous coronary intervention (44 (46%) v 32 (36%) respectively; p=NS).
Conclusion: Patients admitted to feeder DGHs with non-ST elevation acute coronary syndromes wait significantly longer for access to invasive coronary assessment and revascularisation than similar patients admitted in the hospital that incorporates the tertiary cardiac centre. This inequity of access is determined by postcode rather than clinical priority.
Full Text
The Full Text of this article is available as a PDF (145.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bertrand M. E., Simoons M. L., Fox K. A., Wallentin L. C., Hamm C. W., McFadden E., de Feyter P. J., Specchia G., Ruzyllo W. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 2000 Sep;21(17):1406–1432. doi: 10.1053/euhj.2000.2301. [DOI] [PubMed] [Google Scholar]
- Braunwald E., Antman E. M., Beasley J. W., Califf R. M., Cheitlin M. D., Hochman J. S., Jones R. H., Kereiakes D., Kupersmith J., Levin T. N. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2000 Sep;36(3):970–1062. doi: 10.1016/s0735-1097(00)00889-5. [DOI] [PubMed] [Google Scholar]
- Cannon C. P., Weintraub W. S., Demopoulos L. A., Vicari R., Frey M. J., Lakkis N., Neumann F. J., Robertson D. H., DeLucca P. T., DiBattiste P. M. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001 Jun 21;344(25):1879–1887. doi: 10.1056/NEJM200106213442501. [DOI] [PubMed] [Google Scholar]
- Collinson J., Flather M. D., Fox K. A., Findlay I., Rodrigues E., Dooley P., Ludman P., Adgey J., Bowker T. J., Mattu R. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK) Eur Heart J. 2000 Sep;21(17):1450–1457. doi: 10.1053/euhj.1999.1995. [DOI] [PubMed] [Google Scholar]
- Kaul P., Fu Y., Chang W. C., Harrington R. A., Wagner G. S., Goodman S. G., Granger C. B., Moliterno D. J., Van de Werf F., Califf R. M. Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network. J Am Coll Cardiol. 2001 Jul;38(1):64–71. doi: 10.1016/s0735-1097(01)01307-9. [DOI] [PubMed] [Google Scholar]
- Lindahl B., Venge P., Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation. 1996 May 1;93(9):1651–1657. doi: 10.1161/01.cir.93.9.1651. [DOI] [PubMed] [Google Scholar]
- Savonitto S., Ardissino D., Granger C. B., Morando G., Prando M. D., Mafrici A., Cavallini C., Melandri G., Thompson T. D., Vahanian A. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999 Feb 24;281(8):707–713. doi: 10.1001/jama.281.8.707. [DOI] [PubMed] [Google Scholar]
- Stubbs P., Collinson P., Moseley D., Greenwood T., Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BMJ. 1996 Aug 3;313(7052):262–264. doi: 10.1136/bmj.313.7052.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallentin L., Lagerqvist B., Husted S., Kontny F., Ståhle E., Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet. 2000 Jul 1;356(9223):9–16. doi: 10.1016/s0140-6736(00)02427-2. [DOI] [PubMed] [Google Scholar]
- Yusuf S., Flather M., Pogue J., Hunt D., Varigos J., Piegas L., Avezum A., Anderson J., Keltai M., Budaj A. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Lancet. 1998 Aug 15;352(9127):507–514. doi: 10.1016/s0140-6736(97)11162-x. [DOI] [PubMed] [Google Scholar]
- van Miltenburg-van Zijl A. J., Simoons M. L., Veerhoek R. J., Bossuyt P. M. Incidence and follow-up of Braunwald subgroups in unstable angina pectoris. J Am Coll Cardiol. 1995 May;25(6):1286–1292. doi: 10.1016/0735-1097(95)00009-S. [DOI] [PubMed] [Google Scholar]